newsfilter
← Latest News
Business Wire·

Guardant Health Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance

GH

Second quarter 2026 revenue growth of 44% driven by strong performance in Oncology and Screening Raises 2026 revenue guidance to $1.34 to $1.36 billion, representing growth of 36% to 38% Guardant Health, Inc.